The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady entry into a market once dominated by Big pharma.
India & EFTA (Iceland, Liechtenstein, Norway and Switzerland) are negotiating Trade and Economic Partnership Agreement (TEPA) that is likely to be finalized within next few weeks.
Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.
India’s $42 billion drug manufacturing industry relies intensely on China, which supplies almost 70% of the active pharmaceutical ingredients that go into making medicines.
The suggestion of a blockbuster merger between the two drugmakers is a sign that the industry is getting back to something resembling business as usual.
Indian pharma companies, which have dominated the world’s generic medicines market, are now hampered by Trump’s policies & lack of expertise in biologics.
SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.
Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.
COMMENTS